FOLH1 and renal cell carcinoma: Nine articles, including 152 patients (133 ccRCC, 19 other RCC subtypes), provided information on the lesion-level detection rate of PSMA PET/CT performed for either staging and evaluation of primary RCC lesions or restaging of metastatic or recurrent RCC.